Research Interests
Keywords: Bioinformatics, computational biology, genetics, genomics, immunology, pathogenesis and infection, systems biology, virology
In the Ferris lab, we use genetically diverse mouse strains to better understand the role of genetic variation in immune responses to a variety of insults. We then study these variants mechanistically. We also develop genetic and genomic datasets and resources to better identify genetic features associated with these immunological differences.
Mentor Training:
- Bias 101
- Safe Zone
Training Program Affiliations:
- Bioinformatics and Computational Biology
- Genetics and Molecular Biology
Publications
Martin Ferris in UNC Genetics News
May 2, 2021
Department of Genetics Publications for April 18 – May 1, 2021
Department of Genetics faculty, postdocs, students and collaborators published thirteen papers during April 18 – May 1, 2021.
March 25, 2021
Dr. Martin Ferris Promoted to Associate Professor in the Department of Genetics
Dr. Martin Ferris Promoted to Associate Professor in the Department of Genetics.
February 22, 2021
Department of Genetics Publications for February 7-20, 2021
Department of Genetics faculty, postdocs, students and collaborators published seven papers during February 7-20, 2021
February 8, 2021
Department of Genetics Publications for Jan. 24 – Feb. 6, 2021
Department of Genetics faculty, postdocs, students and collaborators published twenty papers during Jan. 24 – Feb. 6, 2021.
November 6, 2020
UNC Researchers Lead International Consortium to Improve Understanding of Genetics of Mouse Models
An international consortium led by UNC Departments of Genetics and Computer Science published a manuscript on the development and testing of a new tool to enhance the value of the laboratory mouse in biomedical research.
November 2, 2020
Department of Genetics Publications for October 11-31, 2020
Department of Genetics faculty, postdocs, students and collaborators published 18 papers during October 11-31, 2020. Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. Fernandez-Martinez A, Krop IE, Hillman DW, Polley MY, Parker JS, Huebner L, Hoadley KA, …
October 1, 2020
Mark Heise, PhD Awarded New R01 Grant from NIAID
Dr. Mark Heise (Professor, Genetics and Microbiology & Immunology) was awarded a new R01 grant from the National Institute of Allergy and Infectious Disease (NIAID) for his project titled “Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross”.
May 4, 2020
Department of Genetics Publications for April 19 – May 2, 2020.
Department of Genetics faculty, postdocs, students and collaborators published nine papers during April 19 – May 2, 2020.
December 4, 2019
Department of Genetics Publications for Nov. 17-30, 2019
Department of Genetics faculty, postdocs, students and collaborators published seventeen papers during Nov. 17-30, 2019.
October 21, 2019
Department of Genetics Publications for October 6-19, 2019
Department of Genetics faculty, postdocs, students and collaborators published nine papers during October 6-19, 2019.